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Our present  understanding  of the mechanisms  involved in activation, specificity, 
and  restriction  of T  cells  is  largely  indebted  to  studies  of cytotoxic  responses  of 
lymphocytes in  vitro.  During  the course  of such  studies, several investigators  (1-5) 
have observed generation of effector cells with the capacity to kill autologous as well 
as allogeneic cells without  any apparent  specificity or restriction in  relation  to  the 
sensitizing antigens/cells. Such phenomena have frequently been dealt with in terms 
of T  cell responses, with  "promiscuous cytotoxicity" (1)  or "specificity for self H-2" 
(2,  4).  More  recently,  however,  this  type  of  culture-induced  reactivity  has  been 
discussed more in relation to natural killer (NK) 1 cells (5-1 1), even if the responsible 
effectors in question express Thy-1 antigen and do not arise in cultures prepared with 
spleen  cells  from  nude  mice  (4,  12).  These  two  interpretations  are  not  necessarily 
contradictory: although many investigators stress the distinction between the NK and 
T  cell systems (13,  14), others are more impressed by the similarities between  them, 
especially at the effector cell level (15,  16). According to one unifying hypothesis (16), 
killing by "specific cytotoxic T  lymphocytes  (CTL),"  "NK  cells," and  "nonspecific 
effector  cells  activated  in  culture"  are  all  different  functions  mediated  by  largely 
overlapping effectors in the T  lineage, the former (CTL function) being dependent on 
a specific receptor system recognizing H-2 alone or as restriction element in connection 
with antigen, and the two latter (seemingly nonspecific functions) based on an as yet 
undefined membrane property enabling the binding to and killing of certain "sensi- 
tive" cells. 
We  have  previously  described  (10)  a  cytotoxic  response  against  NK-sensitive 
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semisyngeneic and xenogeneic tumor cell lines occurring early in the murine mixed 
leukocyte culture (MLC)  combination (CBA ×  A/Sn)Fr--~C57B1. The effector cells 
in this system, which were characterized as Thy-l.2-positive blasts, are one example 
of nonspecific effector cells activated in culture described above. These anomalous 
killer (AK) cells represent a striking analogy to nonspecific Thy-1  + killer cells elicited 
in  the  response  to  certain  virus  infections in  vivo  (10).  In  the  present  study,  we 
investigated the relation between anomalous killing and the phenomena of natural as 
well as specific CTL killing. The results indicate that MLC-generated AK cells are 
derived from NK cells, which have been activated and have undergone surface marker 
modulation under the influence of antigen-stimulated  T  cells. 
Materials and Methods 
Animals.  Mice of the following inbred strains and F1 hybrids were bred in our own animal 
colony: CBA, A/Sn (A), C57B 1/6 (C57B 1), C57B 1 +/bg  d, C57B 1  bgJ/bg  d (C57B 1 bg/bg), DBA/ 
2  (DBA),  (CBA  X A)F1, and (A X C57B1)F1.  BALB/c, BALB/c nu/nu,  BALB/c +/nu,  and 
C57B1 nu/nu  mice were purchased from GI. Bomhotg~.rd  Ltd., 8860 Ry, Denmark. Random- 
bred Swiss +/nu  and nu/nu  littermates were a  kind gift  from Dr.  Beppino Giovanella, The 
Stehlin Foundation for Cancer Research, Houston, TX. 
Adult thymectomy.  Surgical thymectomy was performed on 3-4-wk-old, anesthesized animals. 
3 wk  later,  the  thymectomized mice and control litter mates received 650  rad whole-body 
irradiation and were reconstituted by intravenous injection of 5-15 ×  106 syngeneic fetal liver 
cells. Mice treated with adult thymectomy, irradiation, and fetal liver reconstitution (AT X 
FL)  according to this protocol did not give antibody responses  (titers  <  1/10)  after challenge 
with the thymus-dependent antigen horse  erythrocytes, whereas control mice (C ×  FL) gave 
titers  >  1/80  when  tested  in  a  hemolysis assay  3-4  wk  after  reconstitution (unpublished 
observation). 
Tumors. YAC-1 is a Moloney virus induced lymphoma derived from the A/Sn strain. YAC- 
ACG, YAC-ACK, and YAC-8 are variant sublines of YAC-1, which have been selected  for low 
NK sensitivity by repeated exposures  to highly efficient NK cells from CBA X A mice in vitro 
and in vivo. The procedure and the variant sublines have been described in detail in a recent 
report  (17). RBL-5  is  a  Rauscher virus-induced C57B1  lymphoma. MPC-11  (mineral oil- 
induced plasmocytoma), RL-d (radiation-induced lymphoma), and WEHI-164 (methylchol- 
anthrene-induced fibrosarcoma) are all derived from the BALB/c strain. The cell  lines were 
maintained as suspension cultures in F-13 medium supplemented with penicillin,  streptomycin, 
and 10% fetal (FCS) or newborn calf serum (NCS). This medium was also used for preparations 
of cells as well as in cytotoxicity and competition assays. 
Preparation of Cells and Cultures. Single-cell suspensions of lymph node or spleen cells were 
prepared in F-13 NCS. After washing and counting, cells were used either directly in a cytotoxic 
assay (day 0, fresh spleen cells) or for cultures: 20-30 ×  106 (usually 25 ×  106) cells were plated 
alone or with 6-15 ×  106 (usually 10 ×  106) irradiated (2,000 rad) stimulator cells in 50-ml 
Falcon tissue culture flasks (Falcon Labware, Oxnard, CA). Thus, the final responder/stimulator 
ratio in MLC  varied between 2:1  and 3:1,  which yielded similar results.  Culture medium 
(RPMI with penicillin-streptomycin,  3 ×  10  -5 M 2-mercaptoethanol, and 10 mM Hepes buffer) 
supplemented with  10%  FCS was  added to a  final volume of 10 ml, and the cultures were 
incubated at 37°C, 5% CO2. 
In some experiments, cultures were set up in Click's medium (18) supplemented with 0.5-1% 
FCS or fresh (CBA × A)F1 normal mouse serum. The most extensively used MLC combination 
was  (CBA  ×  A)F1 responders against irradiated C57B1  stimulator cells,  denoted  (CBA  X 
A)Fr--~C57B lx. 
For mitogen stimulation, triplicate aliquots of 2 ×  10  ~ cells were incubated in a  0.15-ml 
volume supplemented with  10%  human AB-serum and  the  mitogen  (phytohemagglutinin 
(PHA):  10  #g/ml,  concanavalin A  (Con  A):  7.5  #g/ml)  in  fiat-bottomed wells  in  Falcon 
microtiter plates. After 72 h, each well was pulsed with 0.5/xCi of [3H]thymidine and incubated 
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individual  samples  were  placed  in  liquid  scintillation  fluid  for  counting  in  a  scintillation 
counter. 
Cytotoxicity Assay.  100/tCi of 51Cr was added  to 4  ×  106 target  cells in 0.3 ml of F-13-NCS 
and  incubated  at  37°C  for  45  min.  Subsequently,  the  cells  were  washed  three  times  and 
suspended  to a  concentration of 2 ×  105/ml.  1 ×  104 cells/50 btl were added  to the log-titered 
effectors in a total volume of 150/~1 in Linbro microtest plates (Linbro Chemical Co., Hamden, 
CT). The plates were incubated 3-6 h  at 37°C in 5% CO2, centrifuged at  1,200  rpm for 3 rain, 
and  then  75  p.1  supernatant  was  collected and  counted  in  a  gammaspectrometer  (Beckman 
Instruments, Fullerton, CA). The spontaneous release was determined by adding target cells to 
medium alone. The spontaneous release did not exceed 20% unless otherwise stated. 
The percentage of lysis was calculated according to the following formula:  ([test counts  - 
spontaneous release]/[total counts -  spontaneous release]) ×  100. Variation of triplicate samples 
was <  15% of the mean, when lysis exceeded 10%. Cytotoxicity of cultured cells below 10% lysis 
was not considered significant. 
Competition Assay. Unlabeled tumor cells were incubated at four different concentrations  (24 
4  4  4  4  5  ×  I0 , 12 ×  10 , 6 ×  10 , and 3 ×  10 ) with a constant  number of effector cells (2 ×  10 ) for 30 
min at 37°C.  1 ×  10  4 51Cr-labeled target cells were then added to a  final volume of 0.15 ml as 
described for cytotoxic assay, and triplicate samples were incubated  for 6 h. Thus, a  constant 
effector/target cell ratio of 20:1  was used in most competition experiments while the number 
of competing unlabeled  tumor  cells were  titrated  out.  The  results  are  expressed  as  percent 
inhibition of specific lysis in control samples (effectors and labeled targets without competitors, 
which yielded 17 to 35% specific lysis). 
Separation of Soy Bean Agglutinin-positive (SBA +) and SBA- Cells. The preparation  of SBA was 
a kind gift from Professor Nathan Sharon, The Weizmann Institute of Science, Rehovot, Israel. 
For separation of spleen cells according to their expression of SBA-receptors, 2 ×  108 splenocytes 
were resuspended in 0.5 ml SBA in phosphate-buffered saline (PBS)  (2 mg/ml). The cells were 
left at room temperature for 5 min with occasional shaking to allow for agglutination of SBA  + 
cells. A 0.25-ml volume of the cell suspension was then gently layered on top of 10 ml bovine 
serum  albumin  (BSA)  diluted  to 2.5%  in PBS  in a  15-ml tube.  The  SBA  + cell formed large 
agglutinates which sedimented rapidly, whereas the single SBA- remained on top of the BSA- 
PBS. After 10 rain of sedimentation, the top (SBA-) and bottom (SBA  +) fractions were collected 
with a  pasteur pipette. The two fractions and the control cells (the remaining 0.25 ml volume, 
which had been mixed with the BSA-PBS without separation)  were then washed twice in 0.2 
M  o-galactose in  PBS  to allow the monosaccarides  to compete specifically for SBA-receptor 
sites, thereby disassociating the agglutinates and washing away the lectin. The cells were then 
washed three times in RPMI-FCS before functional testing or culture. 
Removal of Adherent and Phagocytic Cells.  500-750 ×  106 cells were incubated on a washed and 
prewarmed nylon wool (NW) (type 200; Fenwal Laboratories, Deerfield, IL) column in a 50-ml 
syringe at  37°C  in  5%  CO2.  After 20  min,  the cells were eluted  and  again  incubated  on  a 
similar column for 45 min. In some experiments, the cells eluted from the second column (NW 
×  2) were incubated with carbonyl iron in RPMI-NCS (2 ×  106 cells/ml) in 50-ml tissue culture 
flasks  at  37°C.  After  40  rain,  the  iron-containing  cells  were  removed  by  decanting  the 
suspensions with a  strong magnet applied to the surface of the flask (NW ×  2 +  Fe/Magnet). 
Treatment with Alloantisera Plus  Complement.  Hyperimmune  alloantisera  were  produced  by 
repeated intraperitoneal immunizations (five at the minimum) of (DBA ×  C57B 1)FI mice with 
CBA spleen, liver, and  kidney  (anti  H-2k), and  CE or (CE  ×  NZB)F1 mice with CBA spleen 
(anti-NK  1.2 [11,  19]),  followed by bleeding, collection, and inactivation of serum. Anti H-2D  b 
serum  ](B10.A(5R)  X  LP.R.III)F~  anti-Bl0,  produced  by  a  similar  protocol  using  thymus, 
spleen and lymph node for immunizations]  was kindly provided by the National Institutes of 
Health  Resources Branch.  Monoclonal  anti-Thy-l.2  (lyophilized ascites  from the F7D5  IgM 
producing  hybridoma)  (20)  was  a  kind  gift  from  Dr.  P.  Lake  and  Dr.  E.  A.  Clark,  then  at 
University College Hospital Medical School, London. 
For specific depletion,  fresh  or culture-derived cells were  incubated  at  a  concentration  of 
107/ml in antiserum or control serum (FCS or NMS) diluted in RPMI in 37°C, 5% CO2. After 
30 min, cells were pelleted and resuspended in a  1/10 dilution of a selected rabbit complement, 
in the same volume as used  for the incubation  of antiserum.  The cells were incubated  for a 388  T-NK  CELL INTERACTION  IN  MIXED  LEUKOCYTE  CULTURE 
further 40 min and then washed three times in RPMI-NCS.  If the suspension was to be used 
for culture, viable cells were counted to equalize the number of plated cells. If the cells were to 
be used for a cytotoxicity assay, they were resuspended in the original volume (corresponding 
to 107 cells/ml before treatment) without equalizing cell concentrations. A 0.1-ml volume from 
this suspension was added to target cells in the cytotoxicity assay.  Thus, the total remaining 
effector cell potential was compared for control and antiserum-treated cells. 
For calculation of percent functional reduction (of mitogen responsiveness or cytotoxicity) of 
the antiserum-treated cells, the following formula was used:  100 -  [([3H]thymidine cpm of (or 
% lysis mediated by) antiserum treated cells)/([3H]thymidine cpm of (or % lysis mediated by) 
control serum treated cells)] X  100. Note that the percent reduction is only a semiquantitative 
reflection of the proportion of cytolytic or  mitogen-responsive cells that  were  killed by  the 
antiserum treatment. 
Interferon Treatment.  The partially purified fl interferon (IFN-fl)  preparation (produced by 
infection of L cells with Newcastle disease virus, sp. act. 2.2 X  10  7 U/mg/ml, 0.053 mg protein/ 
ml) was purchased from Calbiochem-Behring Corp., (La Jolla, CA). YAC-1 cells were incubated 
at 0.5 ×  108 eells/ml in RPMI-FCS with 5 ×  103 U of IFN-fl/ml for 16 h (21). Control samples 
of YAC-1  cells without IFN were incubated in parallel. The cells were washed  twice before 
labeling with 51Cr. 
Results 
Kinetics and Specificity of Anomalous Killing Generated in Different  Types of MLC.  MLC 
in  autologous  mouse  serum:  (CBA  X  A)Fr-*C57BlxMLC  in  Click's  medium  with 
0.5-1% autologous (CBA ×  A)  mouse serum (NMS)  yielded an anti YAC-1  response 
peaking by day 4-5,  shortly before  the allospecific killing (Table  I).  The kinetics of 
both responses were thus somewhat  delayed in comparison with MLC  in FCS  (10). 
Control cultures without stimulator cells in NMS showed no signs of blastogenesis or 
proliferation  and  yielded  a  very  poor  recovery  of lymphocytes  (<5%)  which  gave 
TABLE  I 
Kinetics of Cytotoxic Responses in Different Types of MLC 
Experl- 
ment 
Responders 
(CBA X A)FI 
(CBA X A)FI 
(CBA x  A)F1 
(CBA x  A)F1 
(CBA X A)F1 
(CBA X A)FI 
(CBA X  A)FI 
(CBA X A)FI 
(CBA X A)FI 
(CBA X A)FI 
1,000 tad 
(CBA X C57BI)FI 
(CBA X C57B I)F1 
(A ×  C57BI)F1 
(A X C57BI)Fx 
Stimulators 
C57B1 
L 
C57B1 
CBA x  A 
A 
C57B1  +/bg 
C57B1 bg/bg 
C57B1  +/bg 
C57B1 
I 
C57BI 
Percent  lysis* 
Serum 
1% NMS:~ 
1% NMS:~ 
1% FCS:~ 
1% PCS:~ 
10% FCS 
10% FCS 
10% FCS 
10% FCS 
10% FCS 
10% FCS 
10% FCS 
10% FCS 
10% FCS 
10% FCS 
Day  1 
124 h) 
0 
10 
6 
16 
19 
18 
14 
30 
23 
8 
12 
16 
Day 3-4 
(60-90 h) 
0 
9 
9 
26 
11 
14- 
15 
50 
49 
4 
12 
36 
4 
16 
YAC-I 
Day 5 
(100  120 h) 
0 
24 
3 
5 
20 
12 
2O 
26 
29 
0 
t5 
25 
Day 6  7 
(120-140 h 
0 
9 
0 
0 
-§ 
RBL-5 
Day 3-4  Day 5 
0  0 
0  49 
0  3 
8  46 
--  9 
--  4 
--  6 
33  71 
39  74 
0  0 
3  2 
3  5 
Day 6  7 
0 
74 
3 
37 
* Effector/target ratio was 50:1, except in experiment  3, where 
:~ In Click's medium. 
§  Not tested. 
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background  values  (<5%  lysis)  when  used  as  effector  cells  against  YAC-1  targets 
(Tables I and II). 
MLC in FCS.  In contrast to the control cultures in NMS, spleen cells kept without 
allostimulation in 1-10% FCS regularly showed variable degrees of blastogenesis and 
cytotoxic  activity.  Some  FCS  batches  tested  during  the  course  of this  study  were 
highly stimulatory and yielded strong cytotoxic responses against a variety of cell lines 
(not shown). Such batches were not used in the experiments in this report, for which 
FCS with low or moderate blastogenic activity (when used at 10% in control cultures) 
were selected.  In some of the experiments,  the anti-YAC-1  activity  in these control 
cultures showed a regeneration after the initial decline during the first  24 h, with the 
peak occurring between days 3 and 6 (i.e., experiment 3 in Table I), whereas in others, 
it  remained  low  throughout the culture  period  (experiments  2  and  5  in Table  I). 
When  C57B1  allostimulator  cells  were  added,  there  was  always  a  regeneration  of 
YAC-1 killing, peaking between 60 and 90 h  (day 3-4), previously termed anomalous 
killing (10)  (Table I). The cytotoxic potential against YAC-1 at this time point varied 
between experiments, but was always stronger in MLC (15-60% lysis) than in control 
cultures (0-20% lysis). In some (but not all) experiments, the activity of allostimulated 
cells  was  somewhat  higher  than  that  of control cells  already  after  24  h  of culture 
(Table  I).  Thus,  whereas  there were  sometimes  small  differences  in  YAC-1  killing 
between  effectors  from  MLC  and  control  cultures  by  days  1  and  5,  the  largest 
difference  and strongest anomalous killing was always seen around day 3-4. For the 
further  experiments  in  this study,  cultures  were  routinely  performed  in  10%  FCS, 
unless otherwise indicated. 
Direct Killing and Cold Target Inhibition  with NK-sensitive  Tumor  Cells and Effectors from 
TABLE II 
Direct Cytotoxicity and Cold Target Inhibition with NK-sensitive Tumor Cells and AK Cells  from 
Different Types of MLC 
Experi-  Responders  Stimulators  Serum 
ment 
Percent lysis*  Percent cold target inhibition 
YAC-I  targets  RBL-5  targets 
Inhibitor 
Target  0  h  70-100  h 
cells 
3:1:~  g:l  12:1  3:1  6:1  12:1 
1  (A  ×  DBA)Ft  --  10% FCS 
(A  X  DBA)Fa  C57BI  10% FCS 
2  (A  x  CBA)F1  --  0.5%  NMS§ 
(A  x  CBA)F1  C57B1  0.5%  NMS§ 
3  BALB/c  --  10% FCS 
BALB/c  DBA  10% FCS 
BALB/c  C57B  1  10% FCS 
YAC-  I  --  5  --  -- 
YAC-I  25  40  YAC-I  80  85  99  19  16  16 
MPC-I  1  10  30  MPC-11  70  75  80  21  19  16 
P815  0  5  P815  10  0  20  20  19  8 
RBL-5  0  20  RBL-5  0  10  20  40  60  100 
YAC-I  --  4  --  --  -- 
YAC-I  --  15  YAC~I  75  100  100  0  0  25 
RBL-5  --  52  RBL-5  0  0  0  35  50  70 
YAC-  I  20  --  --  -- 
RI~  --  5  --  --  -- 
RLd  --  14  -- 
P815  --  3  --  -- 
YAC-1  26  39  --  --  -- 
RL~  9  20  --  -- 
P815  0  6  --  --  -- 
RBL-5  --  70  --  --  -- 
*  Effector/target ratio was 50:1. 
:~ Inhibitor/target  ratio.  Effector/target  ratio  was 20:1. 
§ In Click's medium. 390  T-NK CELL INTERACTION IN MIXED LEUKOCYTE CULTURE 
Different MLC Responder/Stimulator  Combinations.  To estimate to what extent radiore- 
sistant  NK cells  among the stimulators  contributed  to  the  YAC-1  killing observed 
after 3-4 d  in MLC, we used C57B1  bg/bg splenocytes (deficient  in  NK activity) as 
irradiated  allogeneic cells to sensitize  (CBA  ×  A)F1  responders.  These cultures  had 
slightly  lower  NK  activity  after  24  h  of  culture  than  MLC  with  C57B1  +/bg 
stimulators  (Table I).  However, there  was no  difference between  the  cultures  with 
respect  to  anomalous  YAC-1  killing  by  75  h  or  allospecific killing  against  RBL-5 
(Table I). When the responder (CBA ×  A)Fi spleen cells were irradiated before MLC, 
there was only low recovery of lymphocytes without any signs of blast transformation 
by day 3- 4  (not shown), and without cytotoxic potential  (Table I). Thus, induction 
of AK required  nonirradiated responder cells, and was not dependent on remaining 
NK activity among irradiated stimulator cells. 
The higher cytotoxic activity in MLC was not merely due to higher cell density in 
these  cultures,  as  (CBA  X  A)F1  cells  cultured  together  with  irradiated  autologous 
(CBA  ×  A)F1  or semisyngeneic A  (F1--~parental  MLC)  cells showed  the  same low 
cytotoxicity as responder ceils cultured without irradiated stimulator cells (Table I). 
However,  in  certain  other  Fa  anti-parental  MLC  combinations  [(CBA  X 
C57B1)F1---~C57B lx and (A X C57B 1)Fa--->C57B ix)l, a reproducible anomalous killing 
response peaking at  day 4  was observed  (Table I). Anomalous  killing against  NK- 
sensitive tumors was also observed in several different allogeneic combinations apart 
from (CBA X A)Fr--~C57Blx, including  (A ×  DBA)F1---~C57Blx.  BALB/c---~C57Blx 
and the Mls disparate BALB/c---~DBA (Table II). 
We have previously shown that AK cells from day 3 (CBA X A)F1----~C57B1 MLC 
lyse a  panel of semisyngeneic or xenogeneic tumor cell lines in the same preferential 
order as fresh  (CBA  X  A)FI NK cells  (10).  This NK-like target selectivity was here 
confirmed for AK derived from MLC using (A X DBA)F1 or BALB/c splenocytes as 
responder cells.  After an initial decline to <10% lysis during the first 24 h  of culture 
(not shown), allostimulated responder cells had regenerated cytotoxicity against the 
highly  NK-sensitive  YAC-1  by  day  3  (Table  II).  The  intermediary  NK-sensitive 
MPC-11  or RLc~ were lysed somewhat less efficiently by the same effectors, whereas 
no killing of the relatively NK-resistant  P815  was observed.  Furthermore, we could 
here demonstrate the NK-like target selectivity also in cold target inhibition  experi- 
ments:  nonlabeled  MPC-11  cells, but  not  P815  cells, competed with  MLC-induced 
YAC-l killing.  No cross competition with the allospecific killing against  RBL-5 was 
seen, regardless of the type of serum used for the MLC (10)  (Table II). 
Direct Killing and Cold Target Inhibition with NK-resistant  YAC Cells.  A similar pattern 
of specificity emerged in tests with YAC-1 cells with low NK sensitivity, obtained by 
phenotypic  modulation  or  variant  selection.  Thus,  IFN-/3 pretreatment  of YAC-1 
cells, which results in "protection" against NK-lysis but not against anti-H-2a-directed 
allospecific CTL (21), clearly decreased sensitivity to AK (Table III). The previously 
described YAC-1 variants selected for resistance to NK-lysis (17) also had a decreased 
sensitivity  to  AK  (Table  III).  This  may  depend  on  reduced  expression  of  NK 
recognition  sites on  these  variants rather than  a  general  resistance  to lysis, as their 
capacity to inhibit  YAC-1  lysis by NK or AK cells was also reduced, and they were 
lysed by allospecific CTL at least as efficiently as YAC-1  (Table II1) (17).  However, 
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TABLE  III 
Specificity  of AK; Direct Cytotoxicity and Cold Target Inhibition  with NK-resistant  YAC-1  Cells 
Percent inhibition of 
Percent lysis  YAC-1 lysis 
(CBA x  A)F1  C57B1  --~ Ax~ 
Fresh spleen  --~ C57B1~*  MLC 
MLC 
100:1  33:1  100:1  33:1  33:1  20:1 
Fresh  (CBA X A)F1 
spleen  C57Blx* MLC 
YAC-I§  2411  18  2411  10  46  16  70  70 
YAC-1 IFN-fl¶  1  i  0  0  53  20  --  -- 
YAC-ACK  2  2  7  2  --  16  3  24 
YAC-ACG  2  2  5  4  --  23  7  29 
YAC-8  4  0  2  0  --  25  23  12 
RBL-5  .......  11 
* MLC effectors harvested after 72 h (day 3). 
MLC effectors harvested after 120 h (day 6); right column represent data from ref. 17, included here for 
comparison. These experiments were performed with the same cultures of variant lines. 
§ Tumor cells were tested as target cells in a 5-h SaCr-release assay, or as cold target inhibitor cells with 
5aCr-labeled YAC-1 cells. Inhlbitor/target cell ratio was 12:1. 
I1 Percent lysis  with the corresponding effectors at 24 h and the nonstimulated effectors at 72 h were both 
<5%. 
¶ See Materials and Methods for details. 
TABLE  IV 
Treatment of Effector  Cells with Alloantisera  or Monoclonal Anti Thy 1.2 Antibody  +  RC 
C57B1  (fresh)  (CBA ×  A)Fn (fresh)  (CBA ×  A)FI ~  C57B1  X  MLC  (80 h) 
Experiment  Treatment  of effector cells  YAC- 1'  YAC-I  YAC-1  RBL-5 
l:1~  1:2  1:4  I:l  1:2  1:4  1:1  1:2  1:4  1:1  1:2  1:4 
FCS§ +  RC  22  20  12  24  16  l0  26  18  12  --  --  -- 
Anti H-2  b +  RC  I 5  2  1[  28  17  11  24  18  12  --  --  -- 
Anti H-2  k  + RC  22  21  11  [  8  7  ~t  [11  8  71  --  --  -- 
Anti Thy  1.2 (100 pg/ml)  --  --  --  22  16  10  ~0  6  6]  --  --  -- 
+  RC 
FCS +  RC  --  --  --  29  19  12  33  25  18  24  17  9 
Anti Thy  1.2 (100 pg/ml)  --  --  --  24  16  9  I 8  4  3[  {-1  0  0 I 
+  RC 
Ant~Thyl2(10.g/.,~)  -  -  -  30  i~  10  p3  9  51  I1  -1  0 I 
I 
+  RC 
*  104 target cells per well in a  5  h  S~Cr-release assay. 
:~ Original cell concentration was  107/ml. After treatment  with serum +  RC, cell suspensions were restored to original volume (1 : 1) and serial dilutions 
were performed  (1:2 and  1:4);  100 #1 effector cells were added  to each well. 
§ FCS and alloantisera  used at a  dilution of 1:15. 
YAC-ACK  and  YAC-ACG  were both  somewhat  better recognized by  AK  than  by 
NK  cells. 
Alloantigen Surface Markers on AK Cells.  Treatment  of effector cells with anti-H-2D  b 
antiserum according to a  protocol that reduced NK  activity of C57B 1 spleen cells by 
80% did not affect the anomalous killing induced in  (CBA ×  A)Fr--~C57B lx cultures 
(Table  IV).  In  contrast,  (DBA  ×  C57B1)F1  anti  CBA  antiserum  (containing high 
titers  of anti  H-2  k  antibodies)  +  rabbit  complement  (RC)  reduced  the  anomalous 
killing and NK activity mediated by fresh (CBA X  A)F1 spleen cells with comparable 
efficiency  (Table  IV).  Thus,  the  vast  majority  of anomalous  killers  in  our  MLC 392  T-NK CELL  INTERACTION IN  MIXED  LEUKOCYTE CULTURE 
combination  express  the alloantigens  of the responder  cells, indicating  that  they are 
derived from this population  and  not  from the irradiated  stimulator  cells. 
Treatment  with CE or (CE ×  NZB)F1 anti-CBA antiserum  +  RC, containing high 
titers ofanti-NK  1.2 antibodies  (11,  19)  was efficient in reducing NK-activity of (CBA 
×  A)F1 spleen cells (Table V). The same treatment caused no or only partial reduction 
of anomalous  killing induced  in allogeneic or F1 antiparental  MLC,  and  allospecific 
killing was not  affected at all  (Table V). 
In our previous study, we found that AK cells, but not fresh NK cells, were sensitive 
to treatment  with monoclonal F7D5  anti-Thy-l.2  antibody  +  RC  (10).  However, we 
were not able to abrogate AK completely by anti-Thy-l.2  treatment.  Furthermore,  it 
has now been reported  by several groups  independently  (21-24)  that  a  proportion  of 
NK  cells do express  low density of Thy-1  antigen,  detected  by  monoclonal reagents. 
We therefore tested  the susceptibility  of freshly or MLC-derived  effector cells to  the 
anti-Thy-l.2  reagent  over a  wide  range  of its  titration  curve.  As seen  in  Fig.  1,  the 
anti-Thy-1.2  ascites preparation  killed virtually all thymocytes  at  a  concentration  of 
1  p.g/ml,  as  evaluated  by  trypan  blue  exclusion  after  a  two-step  procedure  with  a 
selected rabbit  serum  as source of complement.  The same concentration  of antibody 
also  killed  30%  of spleen  cells,  with  the  remaining  population  showing  intact  NK 
activity, but no proliferative response to Con A  or PHA.  However, a  slight reduction 
of NK activity (10-25%)  was seen when higher concentration of the ascites preparation 
was  used  (0.01-10  mg/ml).  With  anomalous  killers,  reduction  was  marked  (70%) 
already with  10/~g/ml and complete with  1 mg/ml.  Allospecific CTL  were even more 
sensitive  (70%  reduction  with  1/*g/ml).  This difference in susceptibility  to anti-Thy- 
1.2 treatment  between anomalous  and  allospecific killers was much smaller than  that 
between AK  and  NK, although  it was observed consistently  (Table IV). 
TABLE  V 
Treatment of Effector Cells with Anti-NK-1.2 Antiserum  +  RC 
Percent  lysis:~ 
Spleen cells cultured 
Fresh  with C57B1 stimulator  Experi-ment  Re,ponder genotype  Treatment of effector cells*  spleen cells  cells 80 h 
YAC- 1  YAC- 1  RBL-5 
1  (CBA × A)Ft  FCS l:30 +  RC  29  --  -- 
Anti-NK 1.2§ 1:40 +  RC  4  --  -- 
2  (CBA x  A)Ft  NMS 1:30 +  RC  --  24  28 
Anti-NK 1.2§ 1:40 +  RC  --  19  25 
3  (CBA x  A)FI  FCS 1:40 +  RC  35  53  49 
Anti-NK 1.211 1:40 +  RC  7  36  48 
4  (CBA × A)Fa  FCS 1:20 +  RC  15  17  -- 
Anti-NK 1.211 1:20 +  Re  2  14  -- 
Anti-NK 1.211 1:40 +  RC  3  13  -- 
5  (CBA × C57B1)F1  FCS 1:30 +  RC  25  25  <5 
F1 antiparental MLC  Anti NK 1.2 1:3011 +  RC  6  21  <5 
* Original cell concentration was 107/ml. After treatment with serum +  RC, 
to original volume and  100 #1 was added to 104 targets. 
2~ 10  4 target  cells per well in a 4-5-h S~Cr-release assay. 
§ CE anti-CBA antiserum. 
]l (CE × NZB)F1 anti-CBA antiserum. 
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FIO.  1.  Titration of monoclonal anti-Thy, l.2 antibody in an RC-dependent assay on splenocytes, 
thymocytes, and MLC-derived effector cells. The diagram shows the proportion of dead (CBA × 
A)F] (freshly derived) spleen cells (0) and thymocytes (~7) as judged by trypan blue exclusion; the 
percent reduction of responsiveness to PHA (A) and Con A (V) of fresh (CBA ×  A)FI splenocytes, 
as measured by [aH]thymidine incorporation by 72 h; the percent reduction of (CBA X A)F1 fresh 
splenocyte-mediated anti-YAC-1 cytotoxieity (NK [C)]); and the percent reduction of MLC-derived 
effector cell [(CBA x  A)F]--~C57Blx,  80 h]-mediated anti-YAC-I  (AK [/X]) and anti-RBL-5 (CTL 
[x]) eytotoxlcity. Percent reduction was calculated by comparison to control cells (see Materials and 
Methods) treated with FCS (1:50)  +  RC. 
Cellular  Requirements for Induction  of Anomalous  Killing.  Our  results  obtained  with 
preirradiated  responder  cells  and  with  treatment  of effector  cells  with  anti  H-2 
antiserum  +  RC  demonstrated  that  AK  derived  from  precursors  present  in  the 
nonirradiated responder population in the MLC. It was therefore possible to investi- 
gate the nature of these precursors by selection or experimental manipulation of the 
responder cells. 
Induction  of AK did  not  require  adherent  or phagocytic cells  in  the  responder 
population  (Table VI). However, if the corresponding cells were removed from the 
stimulator population,  no AK was observed day 4  (Table VI), and  it was still  not 
detectable by day 6  (data not shown). The allospecific response was also reduced by 
this treatment of the stimulator cells, as previously reported (25). 
SBA binds to and agglutinates NK cells and B cells, but not mature T  cells, which 
lack the receptor for this lectin  (26). 2 Responder spleen cells depleted of NK and B 
cells by agglutination with SBA gave a  poor AK response, although they yielded an 
equally  efficient  allospecific  CTL  response  as  compared with  control  spleen  cells, 
which had been incubated with the lectin without separation of SBA  + and SBA- cells 
(Table VII). Lymph node cells from the same group of animals gave a similar picture: 
they were less  efficient  in  NK lysis day 0,  showed  no or little  AK, yet produced  a 
highly efficient allospecific CTL response (Table VII). 
These results indicated  that  the AK potential of the responder population  might 
depend on its content of NK cells. In further support of this, we found that treatment 
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TABLE  VI 
Induction of AK Requires Adherent Cells in the Stimulator Population 
Responder cells*  Stimulator cells 
Percent lysis 
YAC- 1  RBL-5 
targets~:  targets 
(CBA ×  A)Fl-unfractionated  --  8 
(CBA ×  A)Fl-unfractionated  C57B1-NW ×  2 +  Fe/Magnet:~  6 
(CBA ×  A)Fx-unfractionated  C57B 1-unfractionated  18 
(CBA ×  A)F1-NW X 2 +  Fe/magn  C57Bl-unfractionated  57 
w 
(CBA x  A)FI-NW ×  2  --  0  1 
(CBA × A)F1-NW  ×  2  C57B1-NW ×  2  1  9 
(CBA x  A)F1-NW X 2  C57Bl-unfractionated  15  34 
* Spleen cells.  Effector cells were harvested from 80 h  cultures and tested at an Effector/target ratio of 
100:1. By 24 h, the cells from the corresponding cultures gave <6% lysis. 
:1: See Materials and Methods. 
TABLE  VII 
Poor AK Response with Responder Cells from Lymph Node and the SBA- Spleen 
Cell Fraction 
Percent lysis:~' 
Stimulator  RBL-5 
Responder cells*  cells  YAC- 1 targets  targets:~ 
0 h  24 h  72 h  120 h 
Total spleen population§  None  30  12  4  --[[ 
C57B1 spleen  12  26  65 
SBA- spleen cells¶  None  7  4  1  -- 
C57B1 spleen  4  4  70 
Lymph node cells  None  5  3  1  -- 
C57B1 spleen  5  3  65 
* All responder cells in this table from the same group of (CBA ×  A)F1 mice. 
:~ Effector/target ratio 50:1. 
§ Incubated with SBA without separation of SBA  ÷ and SBA- cells. 
I[ Not done. 
¶ Incubated with SBA followed  by removal of agglutinated, SBA  + cells by sedimen- 
tation on 2.5% BSA. 
of responder  cells  with  anti-NK-1.2  sera  +  RC  before  MLC  reduced  NK  and  the 
MLC  induced  AK  drastically,  whereas  allospecific  killing  was  actually  somewhat 
enhanced  (Fig.  2). 
Thus,  suppression  of  the  early,  anomalous  killing  did  not  alter  the  subsequent 
allospecific response significantly. Conversely,  it was possible to induce normal  levels 
of AK  in populations with impaired  potential for allospecific killing. Splenocytes from 
mice treated with  adult  thymectomy,  irradiation,  and  reconstitution  with  fetal  liver 
cells  were  able  to  generate  early  YAC-1  killing  in  MLC,  whereas  the  allospecific 
response to RBL-5  was virtually abolished (Table VIII). Responder  cells from normal 
mice depleted  of Thy-l.2-positive  cells by the monoclonal  reagent at a  dilution of 10 
#g/ml  +  RC also yielded normal AK  levels and suppressed allospecific activity (Table 
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Fro.  2.  Cytotoxic responses of (CBA × A)F1 spleen cells treated with anti-NK 1.2 antiserum before 
MLC.  The  diagrams  show  percent  lysis  with  responder cells  treated  with  FCS  (1:30)  +  RC 
(--X--) or antiserum (1:30)  +  RC (O) before allostimulation with C57B1  cells, and control cells 
treated with FCS (l:30) +  RC and then cultured without allogeneic stimulator cells  (--×--).  The 
anti-NK  1.2  antiserum  was  CE  anti-CBA  in  experiment  I  and  (CE  ×  NZB)FI  anti-CBA  in 
experiment II. Effector/target ratio was 50:1. 
TABLE  VIII 
AK Response of (CBA  X  A)FI Cells with Depressed  Allospeclfic CTL Potential 
Percent lysis:~ 
Stimulator 
Experiment  Responder cells and treatment*  cells  YACol  RBL-5 
80 h  120 h  80 h  120 h 
1  (CBA ×  A)F] control (× FL)  C57B1  47  28  38  49 
(CBA × A)FI thymectomy (AT  C57B1  44  31  10  10 
X FL) 
2  (CBA ×  A)FrFCS  1/50 +  RC  None  15  --  2  -- 
C57B1  29  8  30  80 
(CBA ×  A)FI anti Thy 1.2 (10  None  l 1  --  1  5 
btg/ml) +  RC  C57B1  46  38  3  23 
* All responder and stimulator were spleen cells. See Materials and Methods for detailed protocols on the 
various treatments of animals and cells. 
:~ Effector/target ratio was 100:1 in experiment 1 and 50:1 in experiment II. 
These results obtained with anti Thy-1.2 pretreatment  of responders were somewhat 
surprising, since the AK  effectors themselves were always sensitive (70% reduction)  to 
the  same  concentration  of anti-Thy-l.2  antibody  (Table  IV).  The  results  therefore 
imply  that  the  AK-precursor  is  a  nonthymus-processed  cell  that  increases  Thy-1 
expression during  activation  in culture.  However,  we could not conclude  that  induc- 
tion of AK is completely independent  of thymus-processed cells. Many  T  cell functions, 
such  as  production  of T  cell  growth  factor  and  IFN  upon  mitogenic  or  antigenic 
stimulation, are radioresistant  (27, 28). Our  thymectomy  protocol did not exclude the 
presence of some remaining,  radioresistant T  cells, and  all our MLC  also included  T 
cells  among  the  irradiated  splenic  stimulator  cells.  To  critically  assess  any  possible 
involvement  of T  cells,  we  therefore  used  congenitally  athymic  nude  mice  as  the 396  T-NK CELL INTERACTION  IN MIXED  LEUKOCYTE  CULTURE 
source of responder as well as stimulator cells. Indeed, when C57B 1 nu/nu spleen cells 
were  used  as stimulators, AK could  be  induced  only with  BALB/c  +/nu,  and  not 
BALB/c nu/nu responders (Table VIII). Similar results were obtained with stimulator 
spleen cells from  thymectomized and reconstituted C57B1  mice and  responder cells 
from Swiss +/nu and nu/nu littermates. The AK of allostimulated cells as well as the 
rather high YAC-1 killing induced with Swiss +/nu cells cultured alone did not occur 
when Swiss nu/nu were used as responders (Table IX). The AK response was partially 
restored by addition of irradiated +/nu  (but  not  by nu/nu)  cells to  the  Swiss nu/nu 
responders (Table IX). 
Comparisons of Anomalous  Killers and  NKc  Cells.  It  has  previously been  reported  (4) 
that cytotoxicity mediated by non-T cells may arise spontaneously in FCS-containing 
cultures.  These  were  defined  by  their  ability to  lyse WEHI-164  fibrosarcoma  cells 
very  efficiently, and  were  termed  "NK~-cells"  (11).  Fig.  3  shows  a  comparison  of 
cytotoxic responses  against YAC-1  and  WEHI-164  in the same control  and  allosti- 
mulated  control  cultures  of (CBA  X  A)F1 spleen  cells.  Efficient  anomalous  killing 
against YAC-1 required allostimulation, and peaked by day 3 or 4. In contrast, NKc 
cells  against  WEHI-164  were  induced  as  efficiently in  the  control  as  in  the  allo- 
stimulated cultures, and showed peak cytotoxicity around day 5  -  6  (as previously 
reported (4,  11). Furthermore, while the YAC-1 killing could be markedly reduced by 
anti-Thy-l.2. +  RC  treatment, the WEHI-164 killing remained intact. These results 
indicate that NK~ and AK cells represent functionally distinct populations. 
Discussion 
In a  previous study (10), we have described AK cells, Thy-1 + cytotoxic cells, which 
are activated early in  (CBA  X  A)Fa ---) C57B1x  MLC  and  lyse semisyngeneic and 
xenogeneic tumor  targets  in the same preferential order as NK-cells. The results of 
the  experiments  presented  here  provided  a  further  insight  in  this  phenomenon, 
TABLE IX 
Induction of AK Requires Thymus-processed Cells 
Anomalous YAC-1 killing after 80 
hrs of culture 
Experiment  Responder cells  Without stimula-  C57B1  nu/nu 
tor cells  stimulator cells 
50:1"  25:1  50:1  25:l 
1  BALB/c  +/nu  3  1  20  14 
BALB/c nu/nu  2  0  0  0 
C57Bl  AT  X  FL 
stimulator cells:~ 
Swiss +/nu  20  15  37  36 
Swiss nu/nu  1  2  9  6 
Swiss nu/nu + Swiss nu/nux§  0  0  6  1 
Swiss nu/nu + Swiss +/nux  7  7  20  15 
*  Effector/target  ratio. 
See Materials and Methods for details on thymectomy protocol. 
§ 20 X 106 irradiated (1,000 tad) nu/nu or +/nu cells added to the culture. KARRE, SEELEY, ERIKSSON,  BURTON, AND KIESSLING  397 
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FIG. 3.  Comparison ofcytotoxic responses to YAC-1 and WEH-164 in control and allostimulated 
spleen cell cultures. Effector cells from (CBA x A)F] (11) and (CBA × A)F1 ~  C57BIx cultures (17) 
were tested in a 5 h 51Cr-release assay at an effector/target  ratio of 100:1. MLC-derived effectors 
were also tested after treatment with monoclonal anti-Thy-1.2 ascites (10/~g/ml) + RC (N), except 
against  WEHI-164 at  80  h.  Cells treated  with  complement  alone (not shown) did  not  differ 
significantly in cytotoxic potential from untreated cells. 
especially with regard to the cellular requirements  and mechanisms of activation for 
anomalous killing. 
Induction of AK depended upon cells that express NK  1.2 and bind SBA. Several 
different  inbred  mouse strains  and  F1  hybrid  crosses could serve as  donors for AK 
responsive  cells,  which  were  derived  from  a  nonadherent  radiosensitive  spleen  cell 
population.  Lymph  node  cells  responded  poorly,  whereas  spleen  depleted  of cells 
expressing a high density of Thy-l.2 antigen as well as spleen from AT ×  FL animals 
responded  like  the  appropriate  controls.  With  the  exception  of radiosensitivity,  all 
these characteristics  fit one operationally defined population,  namely NK cells  (28). 
It  is  therefore  conceivable  that  the  only  cells  required  among  the  responders  are 
closely related, if not identical to NK cells (phenotype: NK 1  +. Thy-1-/weak), and that 
these are the direct precursors of AK cells (phenotype: NK-1 -/weak. Thy-l+). 
Furthermore, induction of AK required immune stimulation. When responder cells 
were incubated in autologous serum alone in the absence of any known antigens, no 
anomalous  killing  was  registered.  Incubation  in  FCS-containing  medium  usually 
induced  at  least  weak cytotoxicity against  YAC-1  cells.  The  addition  of irradiated 
allogeneic  spleen  cells  to the cultures  reproducibly  resulted  in stronger  anti  YAC-1 
cytotoxicity, regardless of whether FCS or NMS was used. Thus, antigen stimulation 
was required  in our system, although it may be that mitogen-induced stimulation of 
the immune system could work as well. Similar to what has been reported for antigen 
and mitogen-induced T  cell activation  (25,  30), adherent  cells were required  for the 
induction  of AK  in  allogeneic  MLC.  We  do  not  know  whether  the  cytotoxicity 
generated  in  cultures  containing  FCS  (but  no stimulator  cells)  represents  the  same 
general phenomenon as alloantigen-induced anomalous killing, but it is probably also 
dependent  on  antigenic  stimulation.  It  is  of course  possible  that  FCS  contains 
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(i.e.,  polyclonally distributed,  nonantigen-specific receptors). However, it is not nec- 
essary to invoke this postulate as the FCS does contain  bovine specific proteins that 
mouse lymphocytes can recognize as antigenic  (31). 
Our results with spleen cells from nu/nu mice demonstrated that the confrontation 
of precursors of AK cells with antigen in the presence of adherent cells is not sufficient 
to induce AK. Mature thymus-processed cells are required as well, although the data 
indicate that these are at least partly radioresistant, and therefore do not necessarily 
have to be included  in the responder population.  It is important to remember that 
allogeneic  MLC  are  bidirectional,  and  even  if proliferation  of stimulator  cells  is 
prevented by irradiation, they may still respond by secretion of interleukins and IFN 
(27,  28).  The antigen  required  for induction  of AK may therefore even be provided 
by the  cytotoxic precursors  themselves, or other  cells  in  the  responder  population, 
which are recognized by the stimulator cells.  Especially in MLC, in which responders 
were depleted  of allospecific CTL potential,  and  in  the  Fa  anti-parental  MLC, this 
may be the major type of antigen recognition taking place in the cultures. 
We therefore suggest that the triggering reaction in our system is antigen recognition 
by T  cells, which subsequently activate NK cells (which may not have to see antigen 
at  all),  as suggested  for a  similar murine system by Pacucci  et  al.  (32,  33)  and  by 
Herberman et al. (34) for a human system. Our interpretation that NK cells are direct 
precursors of AK cells is enforced by the observation that the two have a very similar 
recognition  pattern.  This  was  shown  most  clearly  by the  results  with  IFN-treated 
YAC-1  cells and  the  YAC-1  variants,  all of which  are  recognized  less  well  by NK 
cells, although they have a  higher or at least as high  H-2 expression as YAC-1  cells 
(17,  21).  We  have  previously  shown  that  K562  cells,  which  do  not  express  any 
detectable HL-A products at all, are sensitive to murine as well as human AK (5,  10), 
suggesting that their recognition is not based on interaction with the MHC products 
on the target cells.  However, we do not imply that all autologous cytotoxicity arising 
in culture is independent of H-2 and mediated by effectors derived from NK-cells. It 
has previously been shown that culturing of murine spleen cells with specific growth 
factors or with certain  batches of FCS  leads to generation  of at least two killer cell 
populations (35), which must be different from AK cells. The NKc-cells (11), probably 
analogous to NKM-cells (35),  seem to be derived from a  splenic natural  effector cell 
directed  primarily against  solid  tumor targets,  the so-called NC cell  (36).  NKc-cells 
lyse  WEHI-164  fibrosarcoma  targets  and  were  shown  here  to  differ  from  AK  by 
several  important  criteria  (Fig.  2).  A  second  type  of killer  cell  arising  in  culture 
without  allostimulation  expresses  Ly-2  apart  from  Thy-1  and  kills  NK-insensitive 
targets such as P815.  As emphasized previously by other investigators (11,  35), such 
cytotoxic effectors share all characteristics of CTL, and  the term NK cells for these 
may cause confusion. Such CTL may be recognizing self-MHC, as described in other 
systems  (37).  Specific,  antiparental  cytotoxicity  induced  in  certain  Fl-antiparental 
MLC  may also  fit  in  this  category of anti-self-MHC  reactions  (38).  However,  the 
specific  Fl-antiparental  effectors show  some  peculiar  characteristics  in  comparison 
with allospecifie CTL;  they cannot be induced  with spleen cells from mice younger 
than 3 wk, nor is it possible to "prime" them with preimmunization  (38).  They may 
therefore be derived from NK-cells, which share these properties, rather than from T 
cells.  If Fl-antiparental  effectors are NK cells,  they should  lyse YAC-1, and indeed, 
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addition to the activity against parental EL-4 cells in  (DBA ×  C57B1)F1  --~ C57B1 
MLC, and we observed a similar generation of YAC-1 killers in other Fl-antiparental 
MLC combinations in the present study. Our results further indicate that failure to 
demonstrate NK 1.2 antigen on cultured effectors is not sufficient evidence to conclude 
that  they  are  conventional  CTL  rather  than  Thy-1 +  NK cells.  The  origin  of Fr 
antiparental effectors in various systems must therefore be studied with fractionation 
of responder cells before MLC. 
The two effector cells induced in allogeneic MLC (anomalous and allospecific) are 
clearly distinguishable at the precursor level, and we conclude that murine anomalous 
killing is not just an additional  function  of conventional specific CTL, as has been 
suggested for culture induced NK-like killers in some human systems (16). Our data 
are more compatible with the reports of Pacucci et al. (32, 33), showing activation of 
non-T killer cells against autologous solid tumors dependent on allostimulated T  cells, 
and of Chun et al. (40), showing activation of NK cells through Con A-stimulated T 
cells. However, our findings differ from these two reports in two respects: AK were 
found to be derived from radiosensitive precursors and to be clearly sensitive to anti 
Thy-l.2 treatment. In the two other systems, NK activation was registered even after 
all input cells had been irradiated and with the effector cells being resistant or only 
marginally sensitive to anti-Thy-1. One factor that may account for these differences 
is  that  we  used  a  response  against  one  allogeneic  donor,  which  although  it  may 
involve  a  high  frequency  of T  cells  (41),  is  still  quite  weak  in  comparison  with 
stimulation  by Con A  (40)  or a  pool of different  allogeneic donors  (33).  Thus, our 
simple  allogeneic  stimulus  would  favor activation  of NK cells  by a  proliferation- 
dependent  process with  concurrent  modulation  of their surface markers to weaker 
expression of NK- 1 and stronger expression of Thy- 1. We have no definite proof that 
AK cells  are  dividing.  However,  they are blasts as judged  by their  distribution  in 
velocity sedimentation (10) and in discontinuous BSA density gradients, (unpublished 
observation).  It is possible to induce  and maintain proliferation of NK-like cells in 
vitro by cultivation in Con A  supernatants  (42)  as well as in purified IL-2 (35, 42). 
Interestingly, cells in such  NK lines  all express Thy-1  antigen,  in contrast  to fresh 
splenic NK cells (42).  One may therefore ask whether these lines really represent NK 
ceils and not conventional T  cells. However, they seem to have the same quantitative 
distribution of certain surface markers as NK cells (42), and we show here that similar 
cells can be observed in MLC only if responder cells contain NK activity, indicating 
that they are derived from NK cells. We therefore suggest that some of the different 
subsets or maturation stages that account for surface marker heterogeneity in the fresh 
NK  population  (22-24)  do  not  survive,  or  alternatively  are  pushed  further  in 
differentiation upon the influence of signals released during an immune response (or 
maintenance in Con A supernatant). This would explain the shift in surface markers 
between the fresh NK population  on one hand,  and AK cells and NK lines on the 
other hand. A phenotype switch has also been observed for human NK cells cultured 
in conditioned media (OKM-1 + OKT-3- ~  OKM-1- OKT-3+; J. Ortaldo, personal 
communication). Our observation that the AK effector cells seem to be more sensitive 
to anti-Yhy-1 treatment than their precursors supports the suggestion of Minato et al. 
(35)  that Thy-1- cells are precursors of Thy-1 + cells within  a  putative NK lineage. 
The same authors concluded that only NK cells of the Thy-1 + phenotype respond to 
IL-2, and Henney et al.  (43)  demonstrated that IL-2 and IFN act synergistically in 400  T-NK CELL  INTERACTION IN MIXED LEUKOCYTE  CULTURE 
NK activation. Because IFN activates NK cells in a proliferation-independent  process 
(44), and because IFN is known to inhibit cell division rather than  to stimulate  it, it 
is  likely that  induction  of AK does  involve other signals  released  in  MLC,  such  as 
IL-2. 
In our previous report (10) we pointed at the similarities between anomalous killers 
and  certain  cytotoxic  responses  elicited  in  vivo  (45,  46).  This  parallel  to  in  vivo 
phenomena  is  now  even  more  apparent,  since  it  has  recently  been  shown  that 
intraperitoneal  injection of allogeneic cells induce Thy-1 ÷ NK cells in the peritoneal 
exudate  (47).  This  occurred  in  H-2  identical  but  Mls-incompatible  combinations 
(similar  to  that  we  observed  in  vitro),  as  well  as  with  single  H-2K,  D,  or  I  locus 
differences. Moreover, it has been demonstrated that "activated" NK-cells from mice 
infected with  lymphocyte choriomeningitis  virus  (LCMV)  are also larger and more 
sensitive to anti-Thy-1.2 treatment  than native NK-cells (48). Although the augmen- 
tation  of NK  activity  appeared  in  parallel  with  increased  splenic  interferon  levels 
already 2-3 d after LCMV infection, the NK-cells with high expression of Thy-1 were 
not  detected  until  5  6  d  after  infection,  in  the  period  preceeding  the  peak  of the 
specific CTL response against  LCMV  (48).  This suggests  that  other  (or additional) 
factors than IFN may be required  for the development of the Thy-1 + NK-phenotype 
in vivo. 
In  conclusion,  the  surface  markers  of NK  cells  and  their  descendents  AK  cells 
indicate that they are more closely related  to T  cells than  to B cells, suggesting that 
the  events  determining  commitment  to the  B  as opposed to T  (and  possibly other) 
lineages  occur earlier  than  acquirement  of NK function  in  the ontogeny. This  does 
not  necessarily  mean  that  NK cells  are  precursors  in  the  T  lineage,  and  that  they 
mature into CTL via the anomalous killer cell stage. In the system described here, the 
two latter functions certainly occurred independently. 
Summary 
Anomalous  killer  cells  are  Thy-1 ÷  blasts  that  are  cytolytic to  the  natural  killer 
(NK)-sensitive  lymphoma YAC-1, and  that  can  be  detected  early  (day  3-4)  in  the 
period  preceeding  the allospecific cytotoxic T  lymphocyte (CTL)  response  in  (CBA 
X  A)F1 ~  C57B1  mixed leukocyte culture  (MLC).  We have investigated  the origin 
and nature of anomalous killing  (AK), with special  emphasis on its relation  to NK- 
and  allospecific  CTL-activity.  AK  was  shown  to  be  distinct  from  the  previously 
described "NKo-cells" induced by cultivation in fetal calf serum (FCS)-supplemented 
medium when these two reactivities  were examined  in parallel.  AK was detected  in 
either FCS- or normal mouse serum (NMS)-supplemented allogeneic MLC, indicating 
that the response was not dependent  on mitogenic or antigenic properties of heterol- 
ogous  serum.  In  addition  to  several  H-2-incompatible  combinations,  AK  was  also 
observed in an Mls-incompatible  (but H-2 compatible) and two Fl-antiparental  MLC 
responder/stinmlator  combinations.  AK cells showed a  similar selectivity pattern  to 
NK  cells,  as  demonstrated  in  cold  target  inhibition  and  direct  cytotoxicity assays 
using variant or interferon-modulated  YAC- 1 cells with low expression of NK target 
structures.  The  AK-cells  were  NK-1.2 -/weak.  Thy-l.2 ÷,  although  they  seem  to  be 
derived  from  non-adherent  radiosensitive  cells  which  are  closely  related,  if  not 
identical,  to NK-cells  (NK-1.2 ÷. Thy-l.2 -/weak, as they could not be readily induced 
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Conversely, an in vivo thymectomy protocol or treatment of normal spleen cells with 
monoclonal anti-Thy-1.2 +  C  reduced the allospecific CTL  response drastically but 
did not affect the AK response. Anomalous killers were not observed when MLC were 
prepared with responder as well as stimulator cells devoid of mature T  cells. In such 
a  combination,  the  AK  response  could  be  partially  restored  by  the  addition  of 
irradiated +/nu  (but not nu/nu)  responder cells to the cultures.  When normal  (non- 
nude)  spleen  cells  were  used  as  responders,  induction  of AK  did  not  require  the 
presence of T  cells in the stimulator population, whereas the removal of adherent and 
phagocytic cells from stimulators abrogated the response. 
Taken  together,  the results suggest  that  AK represents activation, blast  transfor- 
mation, and surface marker modulation of NK cells induced by alloantigen-stimulated 
T  cells, resulting in Thy-1 + cytolytic cells with similar properties to those described 
for NK lines, Although AK cells may be regarded as a more T  cell-like NK phenotype, 
their induction  is neither necessary, nor sufficient  for generation of specific CTL  in 
MLC. 
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